Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 54 of 54 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 01/31/22
End: 05/22/23
Due: 05/22/24
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 09/30/25
Due: 09/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens | NCT01944722 | Becton, Dickinson and Company | user2@example.com | None | 2013-08-31 | 2016-03-31 | 2017-03-31 | - | - | 2025-07-14 |
| Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients | NCT01120444 | Becton, Dickinson and Company | user2@example.com | None | 2010-04-30 | 2010-10-31 | 2011-10-31 | - | - | 2025-07-14 |
| A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors | NCT05130762 | Becton, Dickinson and Company | user2@example.com | None | 2022-01-31 | 2023-05-22 | 2024-05-22 | - | - | 2025-07-14 |
| BD SiteRite(TM) 9 Ultrasound System - Clinical Study | NCT06632509 | Becton, Dickinson and Company | user2@example.com | None | 2025-06-30 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |